Spectrum Pharmaceuticals Agrees to Acquire Allos Therapeutics After Apaziquone Setback
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 4 (Table of Contents)
Published: 17 Apr-2012
DOI: 10.3833/pdr.v2012.i4.1713 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Spectrum Pharmaceuticals has agreed to buy the cancer drug developer Allos Therapeutics for US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS